Marco M. Altaras

2.9k total citations
108 papers, 2.2k citations indexed

About

Marco M. Altaras is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Genetics. According to data from OpenAlex, Marco M. Altaras has authored 108 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Reproductive Medicine, 35 papers in Obstetrics and Gynecology and 31 papers in Genetics. Recurrent topics in Marco M. Altaras's work include Endometrial and Cervical Cancer Treatments (31 papers), Ovarian cancer diagnosis and treatment (31 papers) and Estrogen and related hormone effects (23 papers). Marco M. Altaras is often cited by papers focused on Endometrial and Cervical Cancer Treatments (31 papers), Ovarian cancer diagnosis and treatment (31 papers) and Estrogen and related hormone effects (23 papers). Marco M. Altaras collaborates with scholars based in Israel, South Africa and United States. Marco M. Altaras's co-authors include Yoram Beyth, Ami Fishman, Mario Cordoba, R. Tepper, Ilan Cohen, Jeremiah Shapira, Ron Tepper, Dror Yigael, Jöelle Bernheim and Ilan Bruchim and has published in prestigious journals such as The Lancet, Cancer and Journal of Allergy and Clinical Immunology.

In The Last Decade

Marco M. Altaras

105 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marco M. Altaras Israel 29 1.1k 1.0k 631 328 313 108 2.2k
Arto Leminen Finland 23 628 0.6× 270 0.3× 159 0.3× 304 0.9× 249 0.8× 38 1.2k
A Fanucchi Italy 24 833 0.7× 631 0.6× 70 0.1× 390 1.2× 420 1.3× 64 1.6k
Soon‐Beom Kang South Korea 24 616 0.5× 821 0.8× 116 0.2× 288 0.9× 312 1.0× 62 1.5k
Katsuhiko Hasumi Japan 27 778 0.7× 905 0.9× 195 0.3× 398 1.2× 377 1.2× 112 1.9k
Samuel S. Lentz United States 26 1.8k 1.6× 2.6k 2.6× 158 0.3× 1.5k 4.5× 712 2.3× 60 3.8k
Giorgio Giorda Italy 23 879 0.8× 613 0.6× 94 0.1× 500 1.5× 306 1.0× 95 1.5k
Abbie L. Fields United States 19 454 0.4× 488 0.5× 243 0.4× 325 1.0× 318 1.0× 43 1.2k
Paul F. Kaminski United States 17 769 0.7× 1.2k 1.1× 202 0.3× 197 0.6× 183 0.6× 41 1.7k
Toshihiko Toki Japan 25 584 0.5× 776 0.8× 81 0.1× 572 1.7× 352 1.1× 67 2.0k
Ming-Shyen Yen Taiwan 18 512 0.5× 518 0.5× 56 0.1× 386 1.2× 160 0.5× 49 1.1k

Countries citing papers authored by Marco M. Altaras

Since Specialization
Citations

This map shows the geographic impact of Marco M. Altaras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco M. Altaras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco M. Altaras more than expected).

Fields of papers citing papers by Marco M. Altaras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco M. Altaras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco M. Altaras. The network helps show where Marco M. Altaras may publish in the future.

Co-authorship network of co-authors of Marco M. Altaras

This figure shows the co-authorship network connecting the top 25 collaborators of Marco M. Altaras. A scholar is included among the top collaborators of Marco M. Altaras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco M. Altaras. Marco M. Altaras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zissin, Rivka, Marjorie Hertz, Myra Shapiro‐Feinberg, et al.. (2001). Primary Serous Papillary Carcinoma of the Peritoneum: CT Findings. Clinical Radiology. 56(9). 740–745. 22 indexed citations
2.
Bruchim, Ilan, Dvora Kidron, Aliza Amiel, Marco M. Altaras, & Moshe Fejgin. (2000). Complete Hydatidiform Mole and a Coexistent Viable Fetus: Report of Two Cases and Review of the Literature. Gynecologic Oncology. 77(1). 197–202. 48 indexed citations
3.
Cohen, Ilan, Ron Tepper, Dov Flex, et al.. (1999). Dose-dependent effect of tamoxifen therapy on endometrial pathologies in postmenopausal breast cancer patients. Breast Cancer Research and Treatment. 53(3). 255–262. 21 indexed citations
4.
Ramus, Susan J., Lynda G. Bobrow, Paul D.P. Pharoah, et al.. (1999). Increased frequency ofTP53 mutations inBRCA1 andBRCA2 ovarian tumours. Genes Chromosomes and Cancer. 25(2). 91–96. 68 indexed citations
5.
Zemer, Ruth, Amiram Fishman, Jöelle Bernheim, et al.. (1998). Expression of Cytokeratin-20 in Endometrial Carcinoma. Gynecologic Oncology. 70(3). 410–413. 16 indexed citations
6.
Litmanovitch, Talia, et al.. (1998). Asynchronous replication of homologous α-satellite DNA loci in man is associated with nondisjunction. Cytogenetic and Genome Research. 81(1). 26–35. 40 indexed citations
7.
Cohen, Ilan, Marco M. Altaras, Jeremiah Shapira, et al.. (1997). Different Coexisting Endometrial Histological Features in Asymptomatic Postmenopausal Breast Cancer Patients Treated with Tamoxifen. Gynecologic and Obstetric Investigation. 43(1). 60–63. 20 indexed citations
8.
Cohen, Ilan, Marco M. Altaras, Jeremiah Shapira, et al.. (1996). Time-Dependent Effect of Tamoxifen Therapy on Endometrial Pathology in Asymptomatic Postmenopausal Breast Cancer Patients. International Journal of Gynecological Pathology. 15(2). 152–157. 42 indexed citations
9.
Fishman, Ami, et al.. (1996). A modified, prolonged desensitization protocol in carboplatin allergy. Journal of Allergy and Clinical Immunology. 98(4). 841–843. 65 indexed citations
10.
Zalel, Yaron, Ron Tepper, Marco M. Altaras, & Yoram Beyth. (1996). Transvaginal sonographic measurements of postmenopausal ovarian volume as a possible detection of ovarian neoplasia. Acta Obstetricia Et Gynecologica Scandinavica. 75(7). 668–671. 14 indexed citations
11.
Klein, Zvi, et al.. (1996). Polyserositis as an Unusual Sign of Methotrexate Toxicity. Gynecologic Oncology. 61(3). 446–447.
12.
Tepper, R., Liat Lerner‐Geva, Marco M. Altaras, et al.. (1995). Transvaginal color flow imaging in the diagnosis of ovarian tumors.. Journal of Ultrasound in Medicine. 14(10). 731–734. 21 indexed citations
13.
Tepper, Ron, Adrian Shulman, Marco M. Altaras, et al.. (1994). The Role of Color Doppler Flow in the Management of Nonmetastatic Gestational Trophoblastic Disease. Gynecologic and Obstetric Investigation. 38(1). 14–17. 12 indexed citations
14.
Shulman, Adrian, et al.. (1994). Estrogen and Progesterone Receptor Expression of Decidual Endometrium in a Postmenopausal Woman Treated with Tamoxifen and Megestrol Acetate. Gynecologic and Obstetric Investigation. 38(2). 127–129. 2 indexed citations
15.
Maymon, Ron, et al.. (1994). Penile Condylomata. Obstetrical & Gynecological Survey. 49(11). 790–800. 7 indexed citations
16.
Altaras, Marco M., Rami Aviram, Ilan Cohen, et al.. (1993). Role of Prolonged Stimulation of Tamoxifen Therapy in the Etiology of Endometrial Sarcomas. Gynecologic Oncology. 49(2). 255–258. 45 indexed citations
17.
Altaras, Marco M., et al.. (1990). Primary paraovarian cystadenocarcinoma: Clinical and management aspects and literature review. Gynecologic Oncology. 38(2). 268–272. 32 indexed citations
18.
Altaras, Marco M., et al.. (1988). Huge mesenteric mucinous cystadenoma in normal pregnancy.. PubMed. 71(6 Pt 2). 1030–2. 20 indexed citations
19.
Jaffe, R, et al.. (1985). Endocervical stromal sarcoma—A case report. Gynecologic Oncology. 22(1). 105–108. 12 indexed citations
20.
Jaffe, R, et al.. (1984). Perioperative mezlocillin prophylaxis in cesarean section.. PubMed. 6(4). 467–74. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026